ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1003

Measuring Economic Value of Morning Stiffness; Consistency Over 1 Year

Risto Tuominen, Public Health, University of Turku, Turku, Finland

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Economics, Evaluation, healthcare management and measure

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services II & III

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Economic evaluation of health care activities requires often measuring clinical symptoms and their changes also in monetary terms. Patients with rheumatoid arthritis (RA) may experience morning stiffness (MS), which varies over time, reflecting both short-term fluctuation in symptoms and long-term disease progression. A method that has been successfully applied to measure symptoms of RA is contingent valuation, and particularly its form called Willingness-To-Pay approach (WTP). In this method, patients are asked the maximum amount they would be willing to pay in order to reach a certain health status. In earlier studies patients with more severe symptoms have been willing to pay higher amounts than those with less symptoms. However, it is not known whether the fluctuation in symptoms is reflected in the amounts produced by WTP method. In order to serve as a useful method for monetary valuation of symptoms, WTP approach should produce values which reflect also the changes in symptoms.

The aim of this study was to determine the within-patient variation in duration of MS over 1 year, and the corresponding monetary equivalents assigned to its changes using WTP methodology.

Methods:

The sample (n=100) comprised patients with RA from Turku University Hospital, Finland. All patients were interviewed twice by a trained interviewer using the same interview, 1 year apart. Patients estimated duration of MS in minutes. They were also asked to estimate how much they would be willing to pay on a daily basis if MS could be reduced by 25%, 50%, 75% and 100%. Weighted average of the monetary assessment for MS reduction was computed. Statistical evaluation was based on paired samples t-test, one way analysis of variance and linear regression model.

Results: After 1 year, there was a highly significant reduction in average MS duration from 44.7 minutes to 41.4 minutes (p<0.001); duration was reduced in 34.7% of patients, unchanged in 34.7% and prolonged in 30.6%. Weighted group average WTP for MS duration reduction was € 13.75 in the first interview and € 14.26 a year later (p<0.001). Changes in MS duration were reflected in within-patient WTP estimates. Among patients with reduced MS, weighted average WTP was reduced by € 18.46, in patients with unchanged duration, weighted average WTP increased by € 4.89, and in patients with increased duration of MS, weighted average WTP increased by € 13.46 (p<0.05). This pattern was statistically significant (p<0.05) for hypothetical reduction in MS duration of 50%, 75% and 100%, but not for 25% reduction in MS duration. Changes in duration of MS explained significantly (p<0.05) the variation in change of WTP for reduction, also when level of income was simultaneously controlled (R2=0.325).

Conclusion:

Duration of MS varied considerably over the 1 year follow-up. WTP estimates and their changes corresponded closely to changes in MS duration. WTP method can be considered a valid method to evaluate the impact of morning stiffness in patients in monetary terms.


Disclosure:

R. Tuominen,
None;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/measuring-economic-value-of-morning-stiffness-consistency-over-1-year/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology